Company
Headquarters: Verdellino, BG, Italy
Employees: 607
CEO: Mr. Marco Francesco Eigenmann
€214.3 Million
EUR as of Jan. 1, 2024
US$236.7 Million
Company | Market Cap (USD) |
---|---|
Zoetis Inc. | $89.09 B |
MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
Takeda Pharmaceutical Company Limited | $47.71 B |
Haleon plc | $38.90 B |
PPD, Inc. | $16.58 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. Its pharmaceutical products include powders and granules, tablets, film-coated tablets, and hard gelatine capsules; and nutraceutical products comprise soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, film-coated tablets, and hard gelatin capsules. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1984 and is based in Verdellino, Italy.
Top 1-year algo backtest: +191.38%
$10,000 in June 2023 would now be $29,138 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Fine Foods & Pharmaceuticals N.T.M. S.p.A. has the following listings and related stock indices.
Stock: MTA: FF wb_incandescent